Article
Chronic hepatitis B virus infection: treatment strategies for the next millennium.
Annals of internal medicine - 2 May 2000
Malik A H, Lee W M
Abstract excerpt
Chronic hepatitis B virus (HBV) infection is a leading cause of cirrhosis and hepatocellular carcinoma worldwide. Its prevalence approaches 10% in hyperendemic areas, such as southeast Asia, China, and Africa. Although chronic HBV infection is seen less frequently in North America and Europe, an estimated 1.25 million persons in the United States are infected. In the past decade, revolutionary strides have been...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
